8928 studies found for:    "Gastrointestinal Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive System
Condition: Gastrointestinal Neoplasms
Interventions: Device: ultrasonic microbubbles;   Drug: platinum and gemcitabine
2 Active, not recruiting Study of Minnelide™ in Patients With Advanced GI Tumors
Condition: Advanced Gastrointestinal Tumors
Intervention: Drug: Minnelide™ 001
3 Unknown  Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors
Conditions: Metastatic Breast Cancer;   Gastrointestinal Tumors
Intervention: Drug: Sorafenib, Capecitabine
4 Active, not recruiting Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Gastro-intestinal Tumors
Conditions: Gastro-intestinal Tumor;   Accurate Staging;   Whole-body Diffusion Weighted MRI;   Non-invasive
Intervention: Procedure: Whole body diffusion MRI
5 Not yet recruiting Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic Surgery
Condition: Gastrointestinal Neoplasms
Interventions: Procedure: Laparoscopic Surgery;   Device: Acupuncture treatment
6 Completed Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
Condition: Upper Gastrointestinal Tumours
Intervention: Drug: Irinotecan, Capecitabine
7 Recruiting Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
Condition: Malignant Digestive System Neoplasm
Interventions: Drug: Alisertib;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Oxaliplatin
8 Completed A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours
Condition: Upper Gastrointestinal Tumours
Intervention: Drug: Irinotecan, 5-Fluorouracil, Leucovorin
9 Recruiting A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.
Condition: Advanced Gastrointestinal Tumors
Interventions: Drug: TAS-102;   Drug: CPT-11;   Drug: Bevacizumab
10 Recruiting Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection
Conditions: Colorectal Neoplasia;   Intestinal Neoplasms;   Digestive Neoplasms;   Digestive System Disease;   Intestinal Disease;   Gastrointestinal Disease;   Gastrointestinal Neoplasm
Interventions: Device: Standard colonoscopy;   Device: EndoRings™
11 Active, not recruiting Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer
Conditions: Gastric Cancer;   Neoplasms;   Gastrointestinal Neoplasms;   Digestive System Neoplasms;   Gastrointestinal Diseases
Interventions: Drug: Chemotherapy;   Biological: Ag-D-CIK
12 Active, not recruiting Low Rectal Cancer Study (MERCURY II)
Conditions: Adenocarcinoma;   Adenocarcinoma, Mucinous;   Carcinoma;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   Neoplasms;   Neoplasms, Cystic, Mucinous, and Serous;   Colorectal Neoplasms;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Digestive System Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Gastrointestinal Diseases;   Intestinal Diseases;   Rectal Diseases
Intervention:
13 Active, not recruiting A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC
Conditions: Colorectal Neoplasms;   Neoplasm Metastasis;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Digestive System Neoplasms
Interventions: Biological: Bevacizumab;   Drug: CPT-11 (Irinotecan);   Drug: 5-FU Bolus;   Drug: 5-FU Infusion;   Drug: l-LV (dl-LV);   Biological: bevacizumab;   Drug: Capecitabine
14 Recruiting Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial
Conditions: Adenocarcinoma;   Rectal Diseases;   Colorectal Neoplasms;   Adenocarcinoma, Mucinous;   Carcinoma;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   Neoplasms;   Neoplasms, Cystic, Mucinous, and Serous;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Digestive System Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Gastrointestinal Diseases;   Intestinal Diseases
Intervention:
15 Active, not recruiting Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Conditions: Adenocarcinoma of the Rectum;   Adenocarcinoma;   Adenocarcinoma, Mucinous;   Carcinoma;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   Neoplasms;   Neoplasms, Cystic, Mucinous, and Serous;   Colorectal Neoplasms;   Intestinal Neoplasms;   Gastrointestinal Neoplasms;   Digestive System Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Gastrointestinal Diseases;   Intestinal Diseases;   Rectal Diseases
Intervention: Other: Patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapy
16 Unknown  Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in Vitro
Condition: Gastrointestinal Neoplasms
Intervention:
17 Recruiting Los Angeles Prospective GI Biliary and EUS Series
Conditions: Biliary Disease;   Pancreatitis;   Gastrointestinal Neoplasms
Intervention: Other: clinical course
18 Completed S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Condition: Gastrointestinal Neoplasms
Intervention: Drug: OIS (Oxaliplatin, Irinotecan, S-1)
19 Completed The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients
Conditions: Gastrointestinal Neoplasms;   Postoperative Complications
Intervention: Drug: low calorie, low nitrogen parenteral nutrition for patient with NRS score 3
20 No longer available A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer
Condition: the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine
Interventions: Device: Mapisal;   Other: Urea hand-foot cream

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years